Aquinox Pharmaceuticals to Present at Canaccord Genuity 34th Annual Growth Conference
06 août 2014 16h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals to Announce Second Quarter Financial Results and Host Conference Call on August 11, 2014
05 août 2014 17h00 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Aug. 5, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Expansion of Ongoing Phase 2 Trials of AQX-1125, Including Acceptance of U.S. IND
02 juin 2014 08h30 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, June 2, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics for...
Aquinox Pharmaceuticals to Present at Upcoming Investor Conferences
21 mai 2014 09h00 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, May 21, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical stage pharmaceutical company discovering and developing targeted...
Corrected - Aquinox Pharmaceuticals Announces Presentation on FLAGSHIP Study at the 2014 American Thoracic Society International Conference
14 mai 2014 18h49 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, May 14, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Presentation on FLAGSHIP Study at the 2014 American Thoracic Society International Conference
14 mai 2014 17h00 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, May 14, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces First Quarter 2014 Financial Results
13 mai 2014 06h00 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, May 13, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Closing of Initial Public Offering
12 mars 2014 12h58 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, March 12, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (Nasdaq:AQXP) announced today the closing of its initial public offering of 4,830,000 shares of its...
Aquinox Pharmaceuticals Prices Initial Public Offering
07 mars 2014 09h00 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, March 7, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. announced today the pricing of its initial public offering of 4,200,000 shares of its common stock at a...